Dev Patel (2024) “Role of Proprotein Convertase Subtilisin Kexin Type 9 Inhibitor Therapy in treatment of Patients with Polycystic Ovary Syndrome: A systemic Review of Metabolic and Cardiovascular Outcomes ”, Journal For International Medical Graduates, 3(1). doi:10.56570/jimgs.v1i1.149.